GRAZYNA JASIENIAK-PINIS ATOPIA Niepubliczny Zaklad Opieki Zdrowotnei Poradnie Specjalistyczne
- Address
- lock Available on a paid plan
GRAZYNA JASIENIAK-PINIS ATOPIA - Specialized Respiratory and Allergy Research Center
GRAZYNA JASIENIAK-PINIS ATOPIA is a specialized private healthcare facility dedicated to advancing the understanding and treatment of respiratory and allergic conditions. The center demonstrates particular expertise in conducting clinical research for complex pulmonary disorders, with a strong focus on severe asthma phenotypes and eosinophilic-driven inflammatory conditions.
- Severe eosinophilic asthma management and novel therapeutic interventions
- Long-term efficacy studies of emerging pharmacological agents in respiratory medicine
- Exacerbation prevention strategies in difficult-to-treat asthma populations
The facility's participation in extended clinical trials, including year-long studies evaluating innovative compounds like dexpramipexole, underscores its commitment to rigorous research methodology and comprehensive patient monitoring. The center serves both adolescent and adult populations, providing specialized care for patients with severe respiratory conditions who require advanced therapeutic approaches beyond conventional treatment options.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Areteia Therapeutics Inc.3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in GRAZYNA JASIENIAK-PINIS ATOPIA Niepubliczny Zaklad Opieki Zdrowotnei Poradnie Specjalistyczne
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2 study to evaluate the efficacy and safety of RPT193 in adults with moderate-to-severe T2-high asthma who are partially controlled on inhaled corticosteroid and long-acting beta 2 agonist therapy | Rapt Therapeutics Inc. | Phase II | Not Recruiting | Nov 2023 | Jun 2024 |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dexpramipexole Dihydrochloride Monohydrate | 3 | Unknown | 2023-04-25 | 2024-10-14 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.